Growth in Children with Steroid Sensitive Nephrotic Syndrome

K R Mohan1, M Kanitkar2

  • 1Graded Specialist (Pediatrics), MH Allahabad, UP:-211001.

Insights

Steroid treatment for childhood nephrotic syndrome can cause growth retardation. Higher cumulative steroid doses in children with steroid-sensitive nephrotic syndrome correlate with more significant growth impairment.

Area of Science:

  • Pediatric Nephrology
  • Endocrinology
  • Growth and Development

Background:

  • Nephrotic syndrome is common in children aged 2-8 years.
  • Steroids are the primary treatment for nephrotic syndrome.
  • Relapsing cases raise concerns about growth impacts.

Purpose of the Study:

  • To investigate the relationship between cumulative steroid dose and growth in children with steroid-sensitive nephrotic syndrome (SSNS).

Main Methods:

  • Retrospective analysis of 35 children with SSNS.
  • Divided into two groups: steroids only, and steroids with other medications.
  • Measured height and calculated SD scores over one year, correlating growth rate with cumulative steroid dose.

Main Results:

  • A negative correlation was observed between cumulative steroid dose and growth rate (Pearson's r = -0.341).
  • This "fair correlation" indicates that increased steroid dosage is associated with greater growth retardation.
  • Group I (steroids only) showed a stronger correlation (r = -0.441) than Group II.

Conclusions:

  • Growth retardation is directly proportional to the cumulative steroid dose in children with SSNS.
  • This highlights the need for careful steroid management to balance efficacy and growth.
  • Further research may explore strategies to mitigate steroid-induced growth issues.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
836
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
418
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
295
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
890
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K